Market Research Logo

gel-e Inc - Product Pipeline Analysis, 2019 Update

Summary

gel-e Inc (gel-e), formerly Remedium Technologies Inc, is a medical device company that provides products for the treatment of acute wounds. The company provides spray foams, bandages, gels, films, and band-aids. It provides proprietary technology platform that helps develop wound treatment and hemostatic materials. The company's products are manufactured using simple scalable modified chitosan base material which is found in shrimps, crabs, insects and mushrooms. Its products are used in clinical settings, routine lacerations, nosebleeds, traumatic injuries, surgical bleeds, burns and diabetic ulcers, among others. gel-e is headquartered in College Park, Maryland, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company gel-e Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company


gel-e Inc Company Overview
gel-e Inc Company Snapshot
gel-e Inc Pipeline Products and Ongoing Clinical Trials Overview
gel-e Inc – Pipeline Analysis Overview
gel-e Inc - Key Facts
gel-e Inc - Major Products and Services
gel-e Inc Pipeline Products by Development Stage
gel-e Inc Pipeline Products Overview
Hemogrip Spray-On Foam
Hemogrip Spray-On Foam Product Overview
Hemostat - Internal Surgical Use
Hemostat - Internal Surgical Use Product Overview
Surgical gel-e
Surgical gel-e Product Overview
Trauma gel-e
Trauma gel-e Product Overview
gel-e Inc - Key Competitors
gel-e Inc - Key Employees
gel-e Inc - Locations And Subsidiaries
Head Office
Recent Developments
gel-e Inc, Recent Developments
Apr 03, 2019: Successful first use of gel-e in a surgical model
Jan 21, 2019: gel-e expands patent estate
Jun 29, 2018: gel-e expands its OTC label
Feb 19, 2018: gel-e receives grant to develop new internal use hemostats
Jan 09, 2018: gel-e Expands Clinical Advisory Board with more Surgical Talent
Dec 22, 2017: gel-e Expands Board of Directors with Domain & Commercial Strategy Expert
Dec 15, 2017: gel-e receives US FDA clearance to expand its bandage product line for Rx and OTC use
Sep 13, 2017: gel-e Expands Core Team with Regulatory, Manufacturing and Financial Talent
Jul 15, 2015: Remedium Technologies Receives FDA Clearance for Hemogrip Technology to Help Stop Bleeding
Apr 16, 2013: Remedium Technologies Awarded $500,000 Phase II NSF SBIR Grant to Test Sprayable Foam for Stopping Traumatic Bleeding
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
gel-e Inc Pipeline Products and Ongoing Clinical Trials Overview
gel-e Inc Pipeline Products by Equipment Type
gel-e Inc Pipeline Products by Indication
gel-e Inc, Key Facts
gel-e Inc, Major Products and Services
gel-e Inc Number of Pipeline Products by Development Stage
gel-e Inc Pipeline Products Summary by Development Stage
Hemogrip Spray-On Foam - Product Status
Hemogrip Spray-On Foam - Product Description
Hemostat - Internal Surgical Use - Product Status
Hemostat - Internal Surgical Use - Product Description
Surgical gel-e - Product Status
Surgical gel-e - Product Description
Trauma gel-e - Product Status
Trauma gel-e - Product Description
gel-e Inc, Key Employees
Glossary
List of Figures
gel-e Inc Pipeline Products by Equipment Type
gel-e Inc Pipeline Products by Development Stage

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report